カテゴリ： MarketLine, 企業調査, 南アフリカ

Distell Group Limited：企業の戦略・SWOT・財務情報

◆英語タイトル：Distell Group Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C9175
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：38
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：南アフリカ
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Distell Group Limited – Strategy, SWOT and Corporate Finance Report
Summary

Distell Group Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Distell Group Limited (Distell) is an investment holding company with interests in liquor-related firms. The company, through its subsidiary, is involved in the production, marketing and distribution of alcoholic beverages. It offers wines, spirits, ciders and ready-to-drink (RTD) beverages. Distell markets its products under the brands Klipdrift, Amarula, Gordon’s, Tassenberg, Durbanville Hills, Nederburg, Drostdy-Hof, Savanna, Le Bonheur, Plaisir de Merle and Uitkyk. The company sells its products across North America, Europe, Africa, Latin America and Asia-Pacific. It operates through primary production sites, secondary production sites and trading depots in South Africa and trading depots in Namibia. The company also operates distribution outlets in Swaziland, South Africa, and Botswana. Distell is headquartered in Stellenbosch, Western Cape, South Africa.

Scope

- Detailed information on Distell Group Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Distell Group Limited in the form of a SWOT analysis
- An in-depth view of the business model of Distell Group Limited including a breakdown and examination of key business segments
- Intelligence on Distell Group Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Distell Group Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Distell Group Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Distell Group Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Distell Group Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Distell Group Limited: Company Overview 8
Distell Group Limited: Overview and Key Facts 8
Distell Group Limited: Overview 8
Distell Group Limited: Key Facts 8
Distell Group Limited: Key Employees 9
Distell Group Limited: Key Employee Biographies 10
Distell Group Limited: Major Products and Services 11
Distell Group Limited: Company History 12
Distell Group Limited: Management Statement 14
Distell Group Limited: Locations and Subsidiaries 17
Distell Group Limited: Key Competitors 19
Distell Group Limited: Company Analysis 20
Distell Group Limited: Business Description 20
Distell Group Limited: SWOT Analysis 21
Distell Group Limited: SWOT Overview 21
Distell Group Limited: Strengths 21
Distell Group Limited: Weaknesses 22
Distell Group Limited: Opportunities 22
Distell Group Limited: Threats 23
Distell Group Limited: Corporate Financial Deals Activity 24
Distell Group Limited: Financial Deals Overview 24
Distell Group Limited: Targets and Partners 26
Distell Group Limited: Top Deals 2014 – 2018YTD* 27
Distell Group Limited: Mergers and Acquisitions 28
Distell Group Limited: Capital Raising 29
Distell Group Limited: Partnership 30
Distell Group Limited: Divestments 31
Distell Group Limited: Private Equity and Ownership 32
Distell Group Limited: Recent Developments 33
Distell Group Limited: News and Events Summary 33
Distell Group Limited: Business Expansion 34
Distell Group Limited: Corporate Governance 34
Distell Group Limited: Financial Deals 34
Distell Group Limited: Financial Performance 35
Distell Group Limited: Strategy and Operations 35
Appendix 36
Contact Us 36
Methodology 36
About MarketLine 37

List of Tables
Table 1: Distell Group Limited: Key Facts
Table 2: Distell Group Limited: Key Employees
Table 3: Distell Group Limited: Company History
Table 4: Distell Group Limited: Locations and Subsidiaries
Table 5: Distell Group Limited: Key Competitors
Table 6: Distell Group Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Distell Group Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Distell Group Limited: M&A Average Deal Size - Value (US$m)
Table 9: Distell Group Limited: Targets and Partners
Table 10: Distell Group Limited: Top Deals 2014 - 2018YTD*
Table 11: Distell Group Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Distell Group Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Distell Group Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Distell Group Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Distell Group Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Distell Group Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Distell Group Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Distell Group Limited: Divestments by Geography (2014 - YTD*2018)
Table 19: Distell Group Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 20: Distell Group Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 21: Distell Group Limited: News and Events Summary
Table 22: Distell Group Limited: Business Expansion
Table 23: Distell Group Limited: Corporate Governance
Table 24: Distell Group Limited: Financial Deals
Table 25: Distell Group Limited: Financial Performance
Table 26: Distell Group Limited: Strategy and Operations

List of Figures
Figure 1: Distell Group Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Distell Group Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Distell Group Limited: M&A Average Deal Size - Value (US$m)
Figure 4: Distell Group Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Distell Group Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Distell Group Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Distell Group Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Distell Group Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Distell Group Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 10: Distell Group Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 11: Distell Group Limited: Divestments by Geography (2014 - YTD*2018)
Figure 12: Distell Group Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 13: Distell Group Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Distell Group Limited：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Hallmark Cards, Inc.：企業の戦略・SWOT・財務情報
    Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vermillion Inc (VRML)：企業の財務・戦略的SWOT分析
    Summary Vermillion Inc (Vermillion) is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, a simple blood test …
  • Evofem Biosciences Inc (EVFM)：製薬・医療：M&Aディール及び事業提携情報
    Summary Evofem Biosciences Inc (Evofem) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes reproductive and contraceptive care products for women. The company’s lead product candidate includes Amphora, a non-hormonal vaginal contraceptive gel for the prevention …
  • Faurecia S.A.：企業の戦略・SWOT・財務分析
    Faurecia S.A. - Strategy, SWOT and Corporate Finance Report Summary Faurecia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • H. Lundbeck AS (LUN)：製薬・医療：M&Aディール及び事業提携情報
    Summary H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) diseases including psychiatric and neurological disorders. Its products are indicate …
  • Pioneer Natural Resources Co (PXD)：企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • DiaMedica Therapeutics Inc (DMA)：企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 …
  • Oilex Ltd (OEX)：企業の財務・戦略的SWOT分析
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Wesfarmers Limited：戦略・SWOT・企業財務分析
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Birla Corporation Ltd：企業の戦略・SWOT・財務情報
    Birla Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Birla Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FitLife Brands Inc：企業の戦略・SWOT・財務情報
    FitLife Brands Inc - Strategy, SWOT and Corporate Finance Report Summary FitLife Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Neoleukin Therapeutics Inc (NLTX)：企業の財務・戦略的SWOT分析
    Summary Neoleukin Therapeutics Inc (Neoleukin), formely Aquinox Pharmaceuticals Inc is a biopharmaceutical company develops next generation immunotherapies to treat immunological disorders. The company's lead drug candidate NL-201 is a combined IL-2 and IL-15 protein therapeutic used as an agonist i …
  • Globe Telecom, Inc.：企業の戦略・SWOT・財務分析
    Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • G-III Apparel Group, Ltd.：企業の戦略・SWOT・財務分析
    G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nipro Corp (8086)：製薬・医療：M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • Quorum Health Corp (QHC)：企業の財務・戦略的SWOT分析
    Summary Quorum Health Corp (QHC) is a healthcare service provider that offers outpatient services. The center owns and leases hospitals and outpatient centers across the US. Its hospitals provides general hospital health-care services including general acute care, emergency room, general and special …
  • H2O Retailing Corp：企業の戦略・SWOT・財務分析
    H2O Retailing Corp - Strategy, SWOT and Corporate Finance Report Summary H2O Retailing Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Allot Ltd (ALLT)：企業の財務・戦略的SWOT分析
    Allot Ltd (ALLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PIQUR Therapeutics AG-製薬・医療分野：企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Sinochem International Corp (600500)：企業の財務・戦略的SWOT分析
    Sinochem International Corp (600500) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆